Skip to main content
. 2011 Aug 26;34(4):347–355. doi: 10.1159/000331064

Table 2.

Clinical and biochemical characteristics of participants with type 2 diabetes

Normo Micro Macro P
n 112 70 34
Age, years 66±11 67±14 66±9 0.78
Male, % 52 65 68
Diabetes duration, years 13±8 14±10 13±8 0.41
BMI 31±6 32±6 35±9 0.06
Systolic blood pressure mm Hg 137±18 136±17 139±17 0.64
Fasting glucose, mmol/1 8.7±2.3 8.2±2.2 9.6±4.0 0.42
HbA1c, % 7.5±1.0 7.8±1.6 8.0±1.6 0.19
AER, μg/min 6.9×/÷1.9 51.0×/÷2.0 688.1×/÷2.1
iGFR, ml/min/1.73m2 66.8±18.4 67.2±21.0 58.7±20.9 0.09
Total cholesterol, mmol/l 4.3±1.1 4.3±1.1 4.2±1.1 0.87
LDL-cholesterol, mmol/l 2.5±0.9 2.6±1.2 2.5±0.9 0.67
HDL-cholesterol, mmol/l 1.1±0.4 1.0±0.3 1.1±0.5 0.22
Triglycérides, mmol/1 1.5±0.9 1.8±1.2 1.7±1.0 0.13
Medication use, %
 ACE inhibitors 52 60 60 0.77
 ARBs 39 46 67 0.18
 β-Blockers 36 28 53 0.27
 Diuretics 41 50 54 0.69
 Statins 74 88 86 0.39

Data are means 8 SD except for AER, which is shown as the geometric mean ×/÷ tolerance factor and medication use, which is displayed as % use. ACE = Angiotensin-converting enzyme; ARB = angiotensin receptor blocker; HbA1c = glycated hemoglobin; iGFR = isotopic GFR.